drugset / Trial / NCT00874887
A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms
RandomizedParallel-groupSingle-blindBasic science
Summary
The purpose of this study is to assess if the presence of BAK in a fluoroquinolone in the study eye affects the development of resistant bacteria on the conjunctiva based upon changes in the surface flora over the course of 2 weeks of topical treatment in healthy adult subjects.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-09
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gatifloxacin | Small molecule | 0.3 % | Topical |
| Comparator | Moxifloxacin | Small molecule | 0.5 % | Topical |
Indications
No indication recorded.